Αποτελέσματα αναζήτησης - "КЕРАТОКОНЪЮНКТИВИТ"

1

Academic Journal

Influence of autological plasma enriched in thrombocytes on lacrimation level in canine keratoconjunctivitis sicca

Συγγραφείς: I.S. Yerin, Y.Y. Voronina, V.I. Parshina, Y.A. Vatnikov

Πηγή: Ветеринария

Θεματικοί όροι: therapy, dogs, ауто2 логичная плазма, терапия, собаки, lacrimation, сухой кератоконъюнктивит, Keratoconjunctivitis sicca, autologous plasma, слёзопродукция, 3. Good health

Σύνδεσμος πρόσβασης: https://openrepository.ru/article?id=245231

View record at OpenAIRE

2

Academic Journal

Changes in matrix metalloproteinases and their inhibitors in the tears and blood serum of patients with herpetic keratoconjunctivitis under the influence of antiherpetic antibodies and nimesulide ; Изменения матриксных металлопротеиназ и их ингибиторов в слезах и сыворотке крови больных герпетическим кератоконъюнктивитом под влиянием антигерпетических антител и нимесулида ; Зміни матриксних металопротеїназ та їхніх інгібіторів у сльозах і сироватці крові хворих на герпетичний кератокон’юнктивіт під впливом антигерпетичних антитіл і німесуліду

Συγγραφείς: Пантєлєєв, П. Г., Гайдаш, І. С.

Πηγή: Pathologia; Vol. 18 No. 1 (2021): Pathologia; 50-57 ; Патология; Том 18 № 1 (2021): Патология; 50-57 ; Патологія; Том 18 № 1 (2021): Патологія; 50-57 ; 2310-1237 ; 2306-8027

Θεματικοί όροι: інфекційний кератокон’юнктивіт, матриксні металопротеїнази, інгібітори матриксних металопротеїназ, імуноглобулін, німесулід, герпетичний кератит, инфекционный кератоконъюнктивит, матриксные металлопротеиназы, ингибиторы матриксных металлопротеиназ, иммуноглобулин, нимесулид, герпетический кератит, infectious keratoconjunctivitis, matrix metalloproteinases, matrix metalloproteinases inhibitors, immunoglobulin, nimesulide, herpetic keratitis

Περιγραφή αρχείου: application/pdf

Relation: http://pat.zsmu.edu.ua/article/view/220205/230670; http://pat.zsmu.edu.ua/article/view/220205

Διαθεσιμότητα: http://pat.zsmu.edu.ua/article/view/220205

View record from BASE

3

Academic Journal

Autoimmune polyglandular syndrome type 1 and eye damage ; Аутоиммунный полиэндокринный синдром типа 1 и поражение глаз

Συγγραφείς: L. Yu. Khamnueva, T. N. Iureva, L. S. Andreeva, E. V. Chugunova, Л. Ю. Хамнуева, Т. Н. Юрьева, Л. С. Андреева, Е. В. Чугунова

Πηγή: Acta Biomedica Scientifica; Том 6, № 6-1 (2021); 19-30 ; 2587-9596 ; 2541-9420

Θεματικοί όροι: мутации гена AIRE, adrenal insufficiency, hypoparathyroidism, keratoconjunctivitis, blepharitis, limbal stem cells, cataracts, mutations, AIRE gene mutations, надпочечниковая недостаточность, гипопаратиреоз, кератоконъюнктивит, блефарит, лимбальные стволовые клетки, катаракта

Περιγραφή αρχείου: application/pdf

Relation: https://www.actabiomedica.ru/jour/article/view/3107/2246; Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990; 322(26): 1829-1836. doi:10.1056/NEJM199006283222601; Buzi F, Badolato R, Mazza C, Giliani S, Notarangelo LD, Radetti G, et al. Autoimmune polyendocrinopathy-candidiasisectodermal dystrophy syndrome: Time to review diagnostic criteria? J Clin Endocrinol Metab. 2003; 88(7): 3146-3148. doi:10.1210/jc.2002-021495; Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, et al. Positional cloning of the APECED gene. Nat Genet. 1997; 17(4): 393-398. doi:10.1038/ng1297-393; Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet. 1997; 17(4): 399-403. doi:10.1038/ng1297-399; Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab. 2006; 91(8): 2843-2850. doi:10.1210/jc.2005-2611; Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol. 2001; 2(11): 1032-1039. doi:10.1038/ni723; Kyewski B, Derbinski J, Gotter J, Klein L. Promiscuous gene expression and central T-cell tolerance: More than meets the eye. Trends Immunol. 2002; 23(7): 364-371. doi:10.1016/s1471-4906(02)02248-2; Kyewski B, Derbinski J. Self-representation in the thymus: An extended view. Nat Rev Immunol. 2004; 4(9): 688-698. doi:10.1038/nri1436; Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol. 2006; 24: 571-606. doi:10.1146/annurev.immunol.23.021704.115601; Ramsey C, Winqvist O, Puhakka L, Halonen M, Moro A, Kämpe O, et al. Aire defi cient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet. 2002; 11(4): 397-409. doi:10.1093/hmg/11.4.397; Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, et al. Projection of an immunological self shadow within the thymus by the Aire protein. Science. 2002; 298(5597): 1395-1401. doi:10.1126/science.1075958; Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol. 2003; 4(4): 350-354. doi:10.1038/ni906; Kuroda N, Mitani T, Takeda N, Ishimaru N, Arakaki R, Hayashi Y, et al. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Airedeficient mice. J Immunol. 2005; 174(4): 1862-1870. doi:10.4049/jimmunol.174.4.1862; Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity. 2005; 23(2): 227-239. doi:10.1016/j.immuni.2005.07.005; Malchow S, Leventhal DS, Nishi S, Fischer BI, Shen L, Paner GP, et al. Aire-dependent thymic development of tumorassociated regulatory T cells. Science. 2013; 339(6124): 1219-1224. doi:10.1126/science.1233913; Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: Known and novel aspects of the syndrome. Ann N Y Acad Sci. 2011; 1246: 77-91. doi:10.1111/j.1749-6632.2011.06308.x; Sato K, Nakajima K, Imamura H, Deguchi T, Horinouchi S, Yamazaki K, et al. A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy, candidiasis and ectodermal dystrophy (APECED), accompanied with progressive muscular atrophy: Case report and review of the literature in Japan. Endocr J. 2002; 49(6): 625-633. doi:10.1507/endocrj.49.625; Yan Z, Gang X, Xie X, Gao Y, Li Z, Wang G. A case report and literature review: Identification of a novel AIRE gene mutation associated with Autoimmune Polyendocrine Syndrome Type 1 in East Asians. Medicine (Baltimore). 2020; 99(18): e20000. doi:10.1097/MD.0000000000020000; Constantine GM, Lionakis MS. Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Immunol Rev. 2019; 287(1): 103-120. doi:10.1111/imr.12714; Bruserud Ø, Oftedal BE, Wolff AB, Husebye ES. AIREmutations and autoimmune disease. Curr Opin Immunol. 2016; 43: 8-15. doi:10.1016/j.coi.2016.07.003; Orlova EM, Sozaeva LS, Kareva MA, Oftedal BE, Wolff AB, Breivik L, et al. Expanding the phenotypic and genotypic landscape of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 2017; 102(9): 3546-3556. doi:10.1210/jc.2017-00139; Garelli S, Dalla Costa M, Sabbadin C, Barollo S, Rubin B, Scarpa R, et al. Autoimmune polyendocrine syndrome type 1: An Italian survey on 158 patients. J Endocrinol Invest. 2021; 44(1): 2493-2510. doi:10.1007/s40618-021-01585-6; Cervato S, Mariniello B, Lazzarotto F, Morlin L, Zanchetta R, Radetti G, et al. Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmunepolyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives. Clin Endocrinol (Oxf). 2009; 70(3): 421-428. doi:10.1111/j.1365-2265.2008.03318.x; Larosa MDP, Mackenzie R, Burne P, Garelli S, Barollo S, Masiero S, et al. Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: Using a new immunoprecipitation assay. Clin Chem Lab Med. 2017; 55(7): 1003-1012. doi:10.1515/cclm-2016-0615; Meager A, Visvalingam K, Peterson P, Möll K, Murumägi A, Krohn K, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006; 3(7): 1152-1164. doi:10.1371/journal.pmed.0030289; Oftedal BE, Bøe Wolff AS, Bratland E, Kämpe O, Perheentupa J, Myhre AG, et al. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clin Immunol. 2008; 129(1): 163-169. doi:10.1016/j.clim.2008.07.002; Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, et al. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2008; 93(11): 4389-4397. doi:10.1210/jc.2008-0935; Mazza C, Buzi F, Ortolani F, Vitali A, Natarangelo LD, Weber G, et al. Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Clin Immunol. 2011; 139(1): 6-11. doi:10.1016/j.clim.2010.12.021; Ferre EMN, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, et al. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016; 1(13): e88782. doi:10.1172/jci.insight.88782; Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998; 83(4): 1049-1055. doi:10.1210/jcem.83.4.4682; Трошина В.В., Гребенникова Т.А., Белая Ж.Е. Клинический случай поздней манифестации первичной надпочечниковой недостаточности в рамках аутоиммунного полигландулярного синдрома 1-го типа. Альманах клинической медицины. 2019; 47(2): 175-179. doi:10.18786/2072- 0505-2019-47-017; Pazderska A, Pearce SH. Adrenal insufficiency – recognition and management. Clin Med (Lond). 2017; 17(3): 258-262. doi:10.7861/clinmedicine.17-3-258; Hellesen A, Bratland Е, Husebye ES. Autoimmune Addison’s disease – An update on pathogenesis. Ann Endocrinol (Paris). 2018; 79(3): 157-163. doi:10.1016/j.ando.2018.03.008; Matteson KJ, Picado-Leonard J, Chung BC, Mohandas TK, Miller WL. Assignment of the gene for adrenal P450c17 (steroid 17α-hydroxylase/17,20 lyase) to human chromosome 10. J Clin Endocrinol Metab. 1986; 63(3): 789-791. doi:10.1210/jcem-63-3-789; Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison’s disease. J Clin Endocrinol Metab. 1994; 78(2): 323-328. doi:10.1210/jcem.78.2.8106620; Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016; 101(2): 364-389. doi:10.1210/jc.2015-1710; Reznik Y, Barat P, Bertherat J, Bouvattier C, Castinetti F, Chabre O, et al. SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook. Ann Endocrinol (Paris). 2018; 79(1): 1-22. doi:10.1016/j.ando.2017.12.001; Еремкина А.К., Ковалева Е.В. Гипопаратиреоз: этиология, клиническая картина, современные методы диагностики и лечения. Альманах клинической медицины. 2016; 44(4): 477-492. doi:10.18786/2072-0505-2016-44-4-477-492; Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, SitgesSerra A, van Biesen W, et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 2015; 173(2): G1-G20. doi:10.1530/EJE-15-0628; Bilezikian JP. Hypoparathyroidism. J Clin Endocrinol Metab. 2020; 105(6): 1722-1736. doi:10.1210/clinem/dgaa113; Rubin MR. Recent advances in understanding and managing hypoparathyroidism. F1000Res. 2020; 9: F1000 Faculty Rev-766. doi:10.12688/f1000research.22717.1; Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, et al. Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011; 26(10): 2317-2337. doi:10.1002/jbmr.483; Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. New Engl J Med. 1990; 322(26): 1829-1836. doi:10.1056/NEJM199006283222601; Chascsa DM, Ferré EMN, Hadjiyannis Y, Alao H, Natarajan M, Quinones M, et al. APECED-associated hepatitis: clinical, biochemical, histological and treatment data from a large, predominantly American cohort. Hepatology. 2021; 73(3): 1088-1104. doi:10.1002/hep.31421; Borchers J, Pukkala E, Mäkitie O, Laakso S. Patients with APECED have increased early mortality due to endocrine causes, malignancies and infections. J Clin Endocrinol Metab. 2020; 105(6): e2207-e2213. doi:10.1210/clinem/dgaa140; Merenmies L, Tarkkanen A. Chronic bilateral keratitis in autoimmune polyendocrinopathy-candidiadis-ectodermal dystrophy (APECED). A long-term follow-up and visual prognosis. Acta Ophthalmol Scand. 2000; 78(5): 532-535. doi:10.1034/j.1600-0420.2000.078005532.x; Shah M, Holland E, Chan CC. Resolution of autoimmune polyglandular syndrome-associated keratopathy with keratolimbal stem cell transplantation: Case report and historical literature review. Cornea. 2007; 26(5): 632-635. doi:10.1097/ICO.0b013e3180415d1a; Thorpe E, Handley H. Сhronic tetany and chronic mycelial stomatitis in a child aged four and one-half years. Am J Dis Child. 1929; 38(2): 328-338. doi:10.1001/archpedi.1929.01930080104011; Gass JD. The syndrome of keratoconjunctivitis, superfi cial moniliasis, idiopathic hypoparathyroidism and Addison’s disease. Am J Ophthalmol. 1962; 54(4): 660-674. doi:10.1016/0002-9394(62)92198-0; Wagman RD, Kazdan JJ, Kooh SW, Fraser D. Keratitis associated with the multiple endocrine deficiency, autoimmune disease, and candidiasis syndrome. Am J Ophthalmol. 1987; 103(4): 569-575. doi:10.1016/s0002-9394(14)74281-3; Solomon A, Ellies P, Anderson DF, Touhami A, Grueterich M, Espana EM, et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell defi ciency. Ophthalmology. 2002; 109(6): 1159-1166. doi:10.1016/s0161-6420(02)00960-0; Dua HS, Gomes JA, Singh A. Corneal epithelial wound healing. Br J Ophthalmol. 1994; 78(5): 401-408. doi:10.1136/bjo.78.5.401; Deng SX, Borderie V, Chan CC, Dana R, Figueiredo FC, Gomes JAP, et al. Global consensus on definition, classification, diagnosis, and staging of limbal stem cell deficiency. Cornea. 2019; 38(3): 364-375. doi:10.1097/ICO.0000000000001820; Wu PY, Chang HW, Chen WL. Neurotrophic keratitis in autoimmune polyglandular syndrome type 1: A case report. BMC Ophthalmol. 2021; 21(1): 17. doi:10.1186/s12886-020-01770-w; Müller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003; 76(5): 521-542. doi:10.1016/s0014-4835(03)00050-2; Chen FY, Lee A, Ge S, Nathan S, Knox SM, McNamara NA. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren’s syndrome. PLoS One. 2017; 12(9): e0184916. doi:10.1371/journal.pone.0184916; Baril C, Vincent A, Héon E, Ali A, MacDonald I, Lueder GT, et al. Retinal degeneration in autoimmune polyglandular syndrome type 1: A case series. Br J Ophthalmol. 2015; 99(11): 1536-1542. doi:10.1136/bjophthalmol-2014-305897; Sakaguchi H, Mizuochi T, Haruta M, Takase R, Yoshida S, Yamashita Y, et al. AIRE gene mutation presenting at age 2 years with autoimmune retinopathy and steroid-responsive acute liver failure: A case report and literature review. Front Immunol. 2021; 12: 687280. doi:10.3389/fimmu.2021.687280; Couturier A, Brézin AP. Ocular manifestations of autoimmune polyendocrinopathy syndrome type 1. Curr Opin Ophthalmol. 2016; 27(6): 505-513. doi:10.1097/ICU.0000000000000306; O’brien CS. The cataract of post-operative tetany with report of three cases. Trans Am Ophthalmol Soc. 1931; 29: 100-139.; Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, et al. Hypoparathyroidism. Nat Rev Dis Primers. 2017; 3: 17055. doi:10.1038/nrdp.2017.55; Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The epidemiology of nonsurgical hypoparathyroidism in Denmark: A nationwide case finding study. J Bone Miner Res. 2015; 30(9): 1738-1744. doi:10.1002/jbmr.2501; Kim SH, Rhee Y, Kim YM, Won YJ, Noh J, Moon H, et al. Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study. PLoS One. 2020; 15(5): e0232842. doi:10.1371/journal.pone.0232842; Мальчугина А.А., Атарщиков Д.С., Липатов Д.В., Мельниченко Г.А. Гипопаратиреоз и катаракта. Клиническая и экспериментальная тиреоидология. 2009; 5(4): 9-14. doi:10.14341/ket2009549-14; Shoback DM, Bilezikian JP, Costa AG, Dempster D, Dralle H, Khan AA, et al. Presentation of hypoparathyroidism: Etiologies; and clinical features. J Clin Endocrinol Metab. 2016; 101(6): 2300-2312. doi:10.1210/jc.2015-3909; https://www.actabiomedica.ru/jour/article/view/3107

Διαθεσιμότητα: https://www.actabiomedica.ru/jour/article/view/3107
https://doi.org/10.29413/ABS.2021-6.6-1.3

View record from BASE

4

Academic Journal

Changes in matrix metalloproteinases and their inhibitors in the tears and blood serum of patients with herpetic keratoconjunctivitis under the influence of antiherpetic antibodies and nimesulide

Πηγή: Pathologia; Vol. 18 No. 1 (2021): Pathologia; 50-57
Патология; Том 18 № 1 (2021): Патология; 50-57
Патологія; Том 18 № 1 (2021): Патологія; 50-57

Θεματικοί όροι: нимесулид, иммуноглобулин, матриксні металопротеїнази, ингибиторы матриксных металлопротеиназ, інгібітори матриксних металопротеїназ, matrix metalloproteinases, infectious keratoconjunctivitis, nimesulide, герпетический кератит, herpetic keratitis, 3. Good health, матриксные металлопротеиназы, інфекційний кератокон'юнктивіт, німесулід, герпетичний кератит, инфекционный кератоконъюнктивит, імуноглобулін, matrix metalloproteinases inhibitors, immunoglobulin

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: http://pat.zsmu.edu.ua/article/view/220205

View record at OpenAIRE Full Text Finder

5

Academic Journal

ТЕЧЕНИЕ И КЛИНИЧЕСКАЯ КАРТИНА, ВОЗРАСТНАЯ И СЕЗОННАЯ ДИНАМИКА ИНФЕКЦИОННОГО КЕРАТОКОНЪЮНКТИВИТА У КРУПНОГО РОГАТОГО СКОТА

Συγγραφείς: V V Koshlyak, A S Zakharov

Θεματικοί όροι: 2. Zero hunger, Абердин-Ангус, сезонная динамика, seasonal dynamics, инфекционный кератоконъюнктивит, cattle, крупный рогатый скот, Aberdeen Angus, infectious keratoconjunctivitis, 3. Good health

Σύνδεσμος πρόσβασης: https://research-journal.org/vet/techenie-i-klinicheskaya-kartina-vozrastnaya-i-sezonnaya-dinamika-infekcionnogo-keratokonyunktivita-u-krupnogo-rogatogo-skota/
https://research-journal.org/wp-content/uploads/2021/08/8-110-2.pdf#page=36

6

Academic Journal

On the prevalence of vernal keratoconjunctivitis and current possibilities of treatment

Συγγραφείς: V. V. Brzheskiy

Πηγή: Российский офтальмологический журнал, Vol 10, Iss 4, Pp 74-81 (2018)

Θεματικοί όροι: весенний кератоконъюнктивит, распространенность, патогенез, лечение, vernal keratoconjunctivitis, prevalence, pathogenesis, treatment, Ophthalmology, RE1-994

Περιγραφή αρχείου: electronic resource

Relation: https://roj.igb.ru/jour/article/view/126; https://doaj.org/toc/2072-0076; https://doaj.org/toc/2587-5760

Σύνδεσμος πρόσβασης: https://doaj.org/article/86af72f3766f45dbbfab7a31afbb7902

View record in DOAJ

7

Academic Journal

Influence of autological plasma enriched in thrombocytes on lacrimation level in canine keratoconjunctivitis sicca ; Влияние аутологичной плазмы, обогащенной тромбоцитами, на уровень слёзопродукции при сухом кератоконъюнктивитеу собак

Συγγραφείς: Yerin I.S., Vatnikov Y.A., Parshina V.I., Voronina Y.Y.

Πηγή: Ветеринария

Θεματικοί όροι: слёзопродукция, lacrimation, Keratoconjunctivitis sicca, therapy, autologous plasma, dogs, сухой кератоконъюнктивит, терапия, ауто2 логичная плазма, собаки

Relation: https://doi.org/10.30896/004224846.2018.21.8.58261; https://openrepository.ru/article?id=245231

Διαθεσιμότητα: https://openrepository.ru/article?id=245231

View record from BASE

8

Academic Journal

SOLID SELECTIVE MEDIUM FOR MORAXELLA EXTRACTION

Συγγραφείς: V. V. Subbotin, D. V. Karaychentsev, V. N. Karaychentsev

Πηγή: Ветеринарная патология, Vol 0, Iss 2, Pp 27-31 (2014)

Θεματικοί όροι: инфекционный кератоконъюнктивит, крупный рогатый скот, диагностика, патологоанатомический материал, питательные среды, моракселлы, Veterinary medicine, SF600-1100

Περιγραφή αρχείου: electronic resource

Relation: https://www.vetpat.ru/jour/article/view/375; https://doaj.org/toc/2949-4826

Σύνδεσμος πρόσβασης: https://doaj.org/article/3cf8f4875c454790873576f04a6716e0

View record in DOAJ

9

Academic Journal

BIOLOGICAL PROPERTIES OF EXTRACTED MORAXELLA BOVIS CULTURES

Συγγραφείς: V. V. Subbotin, D. V. Karaychentsev, V. N. Karaychentsev

Πηγή: Ветеринарная патология, Vol 0, Iss 2, Pp 31-34 (2014)

Θεματικοί όροι: инфекционный кератоконъюнктивит, крупный рогатый скот, диагностика, биохимические, патогенные свойства моракселл, Veterinary medicine, SF600-1100

Περιγραφή αρχείου: electronic resource

Relation: https://www.vetpat.ru/jour/article/view/376; https://doaj.org/toc/2949-4826

Σύνδεσμος πρόσβασης: https://doaj.org/article/694d56a7093a4f34af420aab3b093406

View record in DOAJ

10

Academic Journal

DISEASES IN BISON (BISON BONASUS): OCCURRENCE AND EPIZOOTIC CHARACTERISTICS OF BACTERIAL DISEASES IN BISON

Συγγραφείς: P. V. Aksenova

Πηγή: Ветеринарная патология, Vol 0, Iss 2, Pp 51-63 (2014)

Θεματικοί όροι: зубр bison bonasus, некробактериоз, актинобациллез, кератоконъюнктивит, гемофилез, микоплазмоз, некротический баланопостит, туберкулез, бруцеллез, листериоз, паратуберкулез, сибирская язва, эпизоотологические данные, Veterinary medicine, SF600-1100

Περιγραφή αρχείου: electronic resource

Relation: https://www.vetpat.ru/jour/article/view/380; https://doaj.org/toc/2949-4826

Σύνδεσμος πρόσβασης: https://doaj.org/article/e3e5362b0c534e1683241ced02bcbf90

View record in DOAJ

11

Academic Journal

OCULAR MANIFESTATIONS OF VIRAL INFECTIONS IN CHILDREN ; ПОРАЖЕНИЯ ГЛАЗ ПРИ ВИРУСНЫХ ИНФЕКЦИЯХ У ДЕТЕЙ

Συγγραφείς: E. Yu. Markovа, N. A. Pron'ko, L. V. Venediktovа, Е. Ю. Маркова, Н. А. Пронько, Л. В. Венедиктова

Πηγή: CHILDREN INFECTIONS; Том 15, № 3 (2016); 57-62 ; ДЕТСКИЕ ИНФЕКЦИИ; Том 15, № 3 (2016); 57-62 ; 2618-8139 ; 2072-8107 ; 10.22627/2072-8107-2016-15-3

Θεματικοί όροι: Офтальмоферон®, epidemic keratoconjunctivitis, avidity, viral keratitis, Ophtalmoferon®, эпидемическиий кератоконъюнктивит, авидность, вирусный кератит

Περιγραφή αρχείου: application/pdf

Relation: https://detinf.elpub.ru/jour/article/view/248/244; Шамшева О.В., Молочкова О.В. Спектр применения отечественного противовирусного препарата в педиатрии // Детские инфекции, 2015;14(4):26—30. Shamsheva O.V., Molochkova O.V. [The Range of Application of Domestic Antiviral Medication in Pediatrics] // Children Infections, 2015;14(4):26—30. (In Russ.); Астахов Ю.С., Соколов В.О., Морозова Н.В. Исследование переносимости и клинической эффективности препарата «Окомистин» в комбинации с препаратом «Офтальмоферон» при лечении аденовирусных заболеваний глаз // Офтальмологические ведомости. 2013;VI(4):51—55. Astakhov Yu.S., Sokolov V.O., Morozova N.V. [The tolerability and clinical efficacy of Okomistin in combination with Ophtalmoferon in the treatment of adenoviral eye diseases]. // Ophthalmology Journal (Ophthalmologic Vedomosti) 2013;VI(4):51—55. (In Russ.); Нероев В.В., Майчук Ю.Ф. Заболевания конъюнктивы. В кн. «Краткое издание национального руководства по офтальмологии». — М., 2014. Гл. 8. С. 367—407. Neroev V.V., Maychuk Yu.F. [The diseases of conjunctiva. Short edition of the National Manual of Ophthalmology]. — Moscow, 2014; Ch8:367—407. (In Russ.); Астахов Ю.С., Рикс И.А. Современные методы диагностики и лечения конъюнктивитов: Методич. руководство. — СПБ., 2007. С. 12—14. Astakhov Yu.S., Riks I.A. [Modern methods of diagnosis and treatment of conjunctivitis: Methodological Guide]. — St. Petersburg, 2007;12—14. (In Russ.); Педиатрия. Национальное руководство. Краткое издание под редакцией А. А. Баранова. Глава 54. Конъюнктивиты и кератиты у детей. — М., 2013. С. 735—749. [Pediatrics. National Manual]. Short Edition, edited by Baranov A.A., — Moscow, 2013;Ch.54: Conjunctivitis and keratitis in children:735—749. (In Russ.); Бржеский В.В., Калинина И.В. Основные направления медикаментозной терапии больных с роговично-конъюнктивальным ксерозом // Медицинский совет. 2015, 11, С.120—125. Brzheskiy V.V., Kalinin I.V. [Key areas of medication-based therapy in patients with corneoconjunctival xerosis] // Meditsinsky Sovet (Medical Council) 2015;(11):120—125. (In Russ.); Азнабаев М.Т., Мальханов В.Б. Аденовирусные и хламидийные заболевания глаз. — Уфа, 1995. 110 с. Aznabaev M.T., Malkhanov V.B. [Adenoviral and chlamydial eye diseases]. — Ufa, 1995;110. (In Russ.); Kaneko H., Suzutani T., Aoki K. et al. Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan // Br J Ophthalmol. 2011. № 95(1). P. 32—36.; Keenlyside R.A., Hierholzer J.C., D'Angelo L.J. Keratoconjunctivitis associated with adenovirus type 37: an extended outbreak in an ophthalmologist's office // J Infect Dis. 1983. № 147(2). P. 191—198.; Маркова Е.Ю. Особенности лечения воспалительных заболеваний глаз у детей // Эффективная фармакотерапия. Педиатрия. №4, 2010, С. 22—25. Markova E.Yu. [Clinical features and treatment of inflammatory eye diseases in children] // Effective Рharmacotherapy. Pediatrics. 2010;(4):22—25. (In Russ.); Murrah W.F. Epidemic keratoconjunctivitis // Ann Ophthalmol. 1988. № 20(1). P. 36—38.; Ozcan A.A., Ersoz T.R., Dulger E. Management of severe allergic conjunctivitis with topical cyclosporin a 0,05% eyedrops // Cornea. 2007. № 26. P. 1035—1038.; Darougar S., Hunter P.A., Viswalingam M., Gibson J.A., Jones B.R. Acute follicular conjunctivitis and keratoconjunctivitis in London // Br J Ophthalmol. 1978. № 62 (12). P. 843—849.; Doan S., Gabison E., Abitbol O. et al. Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis // J Fr Ophtalmol. 2007. № 30. P. 697—701.; Reinhard T., Godehardt E., Pfahl H.G., Sundmacher R. Local cyclosporine A in nummuli after keratoconjunctivitis epidemica. A pilot study // Ophthalmologe. 2000. № 97. P. 764—768.; Рябцева А. А., Таранникова С. В. Опыт использования препарата Офтальмоферон в клинической практике офтальмологии: Отчет. МОНИКИ имени М. Ф. Владимирского. — М., 2011. 5, С. 24. Ryabtseva A.A., Tarannikova S.V. [The Ophtalmoferon experience in the clinical practice of ophthalmology]. Clinical study report. M.F. Vladimirskiy Moscow Reginal Research and Clinical Institute. — Moscow, 2011;5:24. (In Russ.); Сомова В.В.,Нестеренко Е.И.,Широкова Н.В. Эпидемический аденовирусный конъюнктивит. Современные подходы к лечению. «Фёдоровские чтения — 2009». — М.,2009(3). С.104—105. Somova V.V., Nesterenko E.I., Shirokova N.V. [Epidemic Adenoviral Conjunctivitis. Modern treatment approaches]. Fedorovskie chteniya (Fedorov papers). — Moscow, 2009;(3):104—105. (In Russ.); Майчук Ю.Ф. Расширение области применения Офтальмоферона® при различных глазных заболеваниях // Катарактальная и рефракционная хирургия. 2012. Т. 12 (1):54—58. Maychuk Yu.F. [Extension of Ophtalmoferon use for treatment of various eye diseases] // Journal of Cataract and Refractive Surgery. 2012;(12):1:54—58. (In Russ.); Яни Е.В. Оценка клинической эффективности глазных капель Офтальмоферон в лечении аденовирусных заболеваний глаз // Новые лекарственные препараты. 2006. № 10. С. 17—19. Yani E.V. [Evaluation of the clinical efficacy of Ophtalmoferon (eye drops) in the treatment of adenoviral eye diseases] // Novye Lekarstvennye Preparaty (New medications) 2006;(10):17—19. (In Russ.); Егоров Е.А. Рациональная фармакотерапия в офтальмологии: Рук. для практикующих врачей / Е.А. Егоров, В.Н. Алексеев, Ю.С. Астахов, В.В. Бржевский, А.Ф. Бровкина и др. Под общ. ред. Е.А. Егорова. — М.: Литтерра, 2004. 954 с. Egorov E.A. [Rational Pharmacotherapy in Ophthalmology: Guidelines for Practitioners]. Egorov E.A., Alekseev V.N., Yu.S. Astakhov Yu.S., Brzhevsky V.V., Brovkin A.F. et al. — Moscow: Litterra; 2004:954. (In Russ.); Каспаров А.А. Офтальмогерпес. — M.: Медицина, 1994. Kasparov A.A. [Ophthalmic Herpes]. — Moscow: Meditsina Publ.; 1994. (In Russ.); Krachmer J.H., Mannis M.J., Holland E.J. Fundamentals, diagnosis and management // Cornea. Elsevier Mosby. 2005;2:1005—1033.; Lyon D.B., Newman S.A. Secondary bacterial keratitis in herpes zoster ophthalmicus // Cornea. 1987;6(4):283—285.; Каспарова Е.А. Гнойные язвы роговицы: этиология, патогенез, классификация // ВЕСТНИК ОФТАЛЬМОЛОГИИ. 2015 (5). С.87—97. Kasparova E.A. [Purulent corneal ulcers: etiology, pathogenesis, classification] // Vestnik Оftal'mologii (Annals of Ophtalmology). 2015; 131(5): 87—97. (In Russ.); Ray M., Nigel L.C.S., Tan A.M. Triple infection keratitis // Eye Contact Lens. 2014;40(3):123—126.; Selinger D.S., Selinger R.C., Reed W.P. Resistance to infection of the external eye: the role of tears // Surv Ophthalmol. 1979; 24(1):33—38.; Wilhelmus K.R. The importance of having lysozyme // Cornea. 1985 1986;4(2):69—70.; Smolin G. The role of tears in the prevention of infections // Int Ophthalmol Clin. 1987;27(1): 25—26.; Evans D.J., Fleiszig S.M.J. Why does the healthy cornea resist Pseudomonas aeruginosa infection? // Am J Ophthalmol. 2013;155(6):961-970.e2.; Kumar A., Yu F-S.X. Toll-Like Receptors and Corneal Innate Immunity // Curr Mol Med. 2006;6(3):327—337.; Каспаров А.А. Инфекционные воспалительные заболевания наружного отдела глаза (вступление к дискуссии) // Вестник офтальмологии. 1987;103(1):61—62. Kasparov A.A. [Infectious inflammatory diseases of the outer part of the eye (the introduction to the discussion)] // Vestnik Oftal’mologii. (Annals of Ophtalmology)1987;103(1):61—62. (In Russ.); Kumar A., Hazlett L.D., Yu F-S.X. Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis // Infect Immun. 2008; 76(1):89—96.; Zhang X., Sun X., Wang Z., Zhang Y., Hou W. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility // Invest Ophthalmol Vis Sci. 2012;53(12):7774—7778.; https://detinf.elpub.ru/jour/article/view/248

Διαθεσιμότητα: https://detinf.elpub.ru/jour/article/view/248
https://doi.org/10.22627/2072-8107-2016-15-3-57-62

View record from BASE

12

Academic Journal

RECURRENT CORNEAL EROSION SYNDROME (a review) ; СИНДРОМ РЕЦИДИВИРУЮЩЕЙ ЭРОЗИИ РОГОВИЦЫ (обзор)

Συγγραφείς: S. V. Trufanov, S. A. Malozhen, E. G. Polunina, E. A. Pivin, L. Yu. Tekeeva, С. В. Труфанов, С. А. Маложен, Е. Г. Полунина, Е. А. Пивин, Л. Ю. Текеева

Πηγή: Ophthalmology in Russia; Том 12, № 2 (2015); 4-12 ; Офтальмология; Том 12, № 2 (2015); 4-12 ; 2500-0845 ; 1816-5095 ; 10.18008/1816-5095-2015-2

Θεματικοί όροι: состояние после LASIK, meibomian gland dysfunction, keratoconjunctivitis sicca, diabetes, post-LASIK, дисфункция мейбомиевых желез, сухой кератоконъюнктивит, диабет

Περιγραφή αρχείου: application/pdf

Relation: https://www.ophthalmojournal.com/opht/article/view/234/257; Letko E., Foster S. Recurrent erosion syndrome. In: Smolin and Thoft’s The Cornea: Scientific foundation and clinical practice. Philadelphia: Lippincot Williams & Wilkins; 2005: 657 661.; Kasparova E.A., Kasparov A.A., Amir M.P. A. N., Marchenko N.R., Makarova M.A., Borodina N.R., Fedorov A.A., Smirennaja E.V. [Recurrent corneal erosion]. Recidivirujushhaja jerozija rogovicy. [Cataract & Refractive Surgery]. Kataraktal’naja i refrakcionnaja hirurgija. 2010; 1: 51 53. (in Russ.).; Hansen E. Om den intermitterende keratitis vesiculosa neuralgica af traumatisk oprindelse. Hospitali-Tidende; 1872; 15: 201 203.; Von Szily. Ueber disjunction des Hornhautepithels. Arh.F. Ophthalmol. 1900; 51: 486.; Chandler P. Recurrent corneal erosion of the cornea. Am.J. Ophthalmol.1945; 28: 355 363.; Hykin P.G., Foss A.E., Pavesio C., Dart J.K. The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye. 1994; 8: 35 40.; McLean E. N., MacRae S. M., Rich L.F. Recurrent erosion. Treatment by anterior stromal puncture. Ophthalmology. 1986; 93: 784 788.; Brown N., Bron A. Recurrent erosion of the cornea. Br.J. Ophthalmol. 1976; 60: 84 96.; Thygeson P. Observations on recurrent erosion of the cornea. Am.J. Ophthalmol. 1959; 47: 48 52.; Weene L.E. Recurrent corneal erosion after trauma: A statistical study. Ann. Ophthalmol. 1985; 17: 521.; Nelson J.D., Williams P., Lindstrom R.L., Doughman D.J. Map-fingerprint-dot changes in the corneal epithelial basement membrane following radial keratotomy. Ophthalmology. 1985; 92: 199 205.; Bron A.J., Burgess S.E. Inherited recurrent corneal erosion. Trans. Ophthalmol. Soc. UK. 1981; 101: 239 243. 1; Hope-Ross M.W., Chell P.B., Kervick G.N., McDonnell P.J. Recurrent corneal erosion: clinical features. Eye. 1994; 8: 373 377.; Friend J., Thoft R.A. The diabetic cornea. Int. Ophthalmol. Clin. 1984; 24: 111 123.; Jenkins M.S., Brown S.I., Lempert S.L., Weinberg R.J. Ocular rosacea. Metab. Pediatr. Syst. Ophthalmol. 1982; 6: 189 195.; Heyworth P., Morlet N., Rayner S., Hykin P., Dart J. Natural history of recurrent erosion syndrome — a 4 year review of 117 patients. Br.J. Ophthalmol. 1998; 82: 26 28.; Eke T., Morrison D.A., Austin D.J. Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye. 1999; 13: 345 347.; Reidy J.J., Paulus M.P., Gona S. Recurrent erosions of the cornea: epidemiology and treatment. Cornea. 2000; 19: 767 771.; Rubinfeld R.S., Laibson P.R., Cohen E.J., Arentsen J.J., Eagle Jr.R. C. Anterior stromal puncture for recurrent erosion: further experience and new instrumentation. Ophthalmic Surg. 1990; 21: 318 326.; Williams R., Buckley R.J. Pathogenesis and treatment of recurrent erosion. Br.J. Ophthalmol. 1985; 69: 435 437.; Dua H.S., Forrester J.V. The corneoscleral limbus in human corneal epithelial wound healing. Am.J. Ophthalmol. 1990; 110: 646 656.; Gipson I.K. Adhesive mechanisms of the corneal epithelium. Acta Ophthalmol. Suppl. 1992; 202: 13 17.; Tripathi R.C., Bron A.J. Ultrastructural study of non-traumatic recurrent corneal erosion. Br.J. Ophthalmol. 1972; 56: 73 85.; Goldman J.N., Dohlman C.H., Kravitt B.A. The basement membrane of the human cornea in recurrent epithelial erosion syndrome. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1969; 73: 471 481.; Aitken D.A., Beirouty Z.A., Lee W.R. Ultrastructural study of the corneal epithelium in the recurrent erosion syndrome. Br.J. Ophthalmol. 1995; 79: 282 289.; Matsubara M., Girard M.T., Kublin C.L., Cintron C., Fini M.E. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Dev. Biol. 1991; 147: 425 439.; Sugrue S.P., Hay E.D. The identification of extracellular matriх (ECM) binding sites on the basal surface of embryonic corneal epithelium and the effect of ECM binding on epithelial collagen production. J. Cell Biol. 1986; 102: 1907 1916.; Fini M.E., Girard M.T. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest. Ophthalmol. Vis. Sci. 1990; 31: 1779 1788.; Dahl M.V., Ross A.J., Schlievert P.M. Temperature regulates bacterial protein production: possible role in rosacea. J.Am. Acad. Dermatol. 2004; 50: 266 272.; Dougherty J.M., McCulley J.P. Analysis of the free fatty acid component of meibomian secretions in chronic blepharitis. Invest. Ophthalmol. Vis. Sci. 1986; 27:52 56.; Afonso A.A., Sobrin L., Monroy D.C., Selzer M., Lokeshwar B., Pflugfelder S.C. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest. Ophthalmol. Vis. Sci. 1999; 40: 2506 2512.; Jester J.V., Petroll W.M., Barry P.A., Cavanagh H.D. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest. Ophthalmol. Vis. Sci. 1995; 36: 809 819.; Fini M.E., Cook J.R., Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch. Dermatol. Res. 1998; 290 (Suppl.): 12 23.; Sivak J.M., Fini M.E. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog. Retin. Eye Res. 2002; 21: 1 14.; Wong T.T., Sethi C., Daniels J.T., Limb G.A., Murphy G., Khaw P.T. Matrix metalloproteinases in disease and repair processes in the anterior segment. Surv. Ophthalmol. 2002; 47: 239 256.; Boudreau N., Bissell M.J. Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr. Opin. Cell Biol. 1998; 10: 640 646.; Mohan R., Chintala S.K., Jung J.C., Villar W.V., McCabe F., Russ.o L.A. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J. Biol. Chem. 2002; 277: 2065 2072.; Garrana R.M., Zieske J.D., Assouline M., Gipson I.K. Matrix metalloproteinases in epithelia from human recurrent corneal erosion. Invest. Ophthalmol. Vis. Sci. 1999; 40: 1266 1270.; Kasparova E.A., Pur Akbarian Niaz A.M. [Recurrent corneal erosion management]. Lechenie recidivirujushhej jerozii rogovicy. [Annals of Ophthalmology]. Vestnik oftal’mologii. 2009; 125 (2): 54 57. (in Russ.).; Pur Akbarian Niaz A.M. [Diagnosis and treatment of recurrent corneal erosion. A review]. Diagnostika i lechenie recidivirujushhej jerozii rogovicy. Obzor. [Ophthalmology]. Oftal’mologiya. 2009; 6 (1): 9 13. (in Russ.).; Kasparova E.A., Kasparov A.A., Marchenko N.R., Pur-Akbarian N.A., Makarova M.A., Borodina N.V., Smirennaja E.V. [Diagnosis and treatment of recurrent herpetic corneal erosion]. Diagnostika i lechenie gerpeticheskoj recidivirujushhej jerozii rogovicy. [Annals of Ophthalmology]. Vestnik oftal’mologii. 2010; 126 (5): 3 8. (in Russ.).; Safonova T.N., Zabegajlo A.O., Fedorov A.A., Lukicheva O.V. [New method of treatment for chronic blepharitis associated with dry eye syndrome.] Novyj sposob lechenija hronicheskogo blefarita, associirovannogo s sindromom suhogo glaza. [Annals of Ophthalmology]. Vestnik oftal’mologii. 2014; 130 (1): 73 78. (in Russ.).; Polunin G.S., Safonova T.N., Fedorov A.A., Polunina E.G., Pimenidi M.K., Zabegajlo A.O. [Chronic blepharoconjunctivitis in dry eye pathogenesis]. Rol’ hronicheskih blefarokon’junktivitov v razvitii sindroma suhogo glaza. [Siberian Scientific Medical Journal]. Sibirskij nauchnyj medicinskij zhurnal. 2009; 29 (4): 123 126. (in Russ.).; Hope-Ross M.W., Chell P.B., Kervick G.N., McDonnell P. J., Jones H.S. Oral tetracycline in the treatment of recurrent corneal erosions. Eye. 1994; 8: 384 388.; Dursun D., Kim M.C., Solomon A., Pflugfelder S.C. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am.J. Ophthalmol. 2001; 132: 8 13.; Ye H.Q., Azar D.T. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest. Ophthalmol. Vis. Sci. 1998; 39: 913 921.; Solomon A., Rosenblatt M., Li D.Q., Liu Z., Monroy D., Ji Z. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest. Ophthalmol. Vis. Sci. 2000; 41: 2544 2557.; Fujikawa L.S., Foster C.S., Harrist T.J., Lanigan J.M., Colvin R.B. Fibronectin in healing rabbit corneal wounds. Lab. Invest. 1981; 45: 120 129.; del Castillo J.M., de la Casa J.M., Sardina R.C., Fernandez R.M., Feijoo J.G., Gomez A.C. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002; 21: 781 783.; Poland D.E., Kaufman H.E. Clinical uses of collagen shields. J. Cataract Refract. Surg. 1988; 14: 489 491.; Kent H.D., Cohen E.J., Laibson P.R., Arentsen J.J. Microbial keratitis and corneal ulceration associated with therapeutic soft contact lenses. CLAO J. 1990; 16: 49 52.; Kasparov A. A, Trufanov S.V. [Preserved amniotic membrane for surface reconstruction of the anterior segment of the eye]. Ispol’zovanie konservirovannoj amnioticheskoj membrany dlja rekonstrukcii poverhnosti perednego otrezka glaznogo jabloka. [Annals of Ophthalmology]. Vestnik oftal’mologii. 2001; 3: 45 47. (in Russ.); Sridhar M.S., Rapuano C.J., Cosar C.B., Cohen E.J., Laibson P.R. Phototherapeutic keratectomy versus diamond burr polishing of Bowman’s membrane in the treatment of recurrent corneal erosions associated with anterior basement membrane dystrophy. Ophthalmology. 2002; 109: 674 679.; Dolzhich R.R., Pjatnicyna V.V., Maljutina I.S. [Pathogenic base and evaluation of the laser anterior stromal puncture in treatment of patients with recurrent corneal erosion]. Patogeneticheskoe obosnovanie i ocenka jeffektivnosti lazernoj perednej korneopunktury v kompleksnom lechenii pacientov s recidivirujushhej jeroziej rogovicy. [Ophthalmosurgery]. Oftal’mohirurgiya. 2009; 5: 21 24. (in Russ.).; Rubinfeld R.S., MacRae S. M., Laibson P.R. Successful treatment of recurrent corneal erosion with Nd:YAG anterior stromal puncture. Am.J. Ophthalmol. 1991; 111: 252 255.; SundarRaj N., Geiss M.J., Fantes F., Hanna K., Anderson S.C., Thompson K.P. Healing of excimer laser ablated monkey corneas. An immunohistochemical evaluation. Arch. Ophthalmol. 1990; 108: 1604 1610.; Lohmann C.P., Gartry D.S., Muir M.K., Timberlake G.T., Fitzke F.W., Marshall J. Corneal haze after excimer laser refractive surgery: objective measurements and functional implications. Eur.J. Ophthalmol. 1991; 1: 173 180.; Dausch D., Landesz M., Klein R., Schroder E. Phototherapeutic keratectomy in recurrent corneal epithelial erosion. Refract. Corneal Surg. 1993; 9: 419 424.; Maini R., Loughnan M.S. Phototherapeutic keratectomy re-treatment for recurrent corneal erosion syndrome. Br.J. Ophthalmol. 2002; 86: 270 272.; Buxton J.N., Fox M.L. Superficial epithelial keratectomy in the treatment of epithelial basement membrane dystrophy. A preliminary report. Arch. Ophthalmol. 1983; 101: 392 39; https://www.ophthalmojournal.com/opht/article/view/234

Διαθεσιμότητα: https://www.ophthalmojournal.com/opht/article/view/234
https://doi.org/10.18008/1816-5095-2015-2-4-12

View record from BASE

13

Academic Journal